LOGIN
ID
PW
MemberShip
2025-09-18 19:06
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter¡¯s View] Real test begins for K-CDMOs
Reporter's view |
Son, Hyung Min
[Reporter's View] Interest Rate Cuts and Investment Revival
Reporter's view |
Kim, Jin-Gu
[Reporter's View] Approval-to-reimbursement takes only 6 mth
Reporter's view |
Lee, Hye-Kyung
INTERVIEW
"Gilead-Kite will lead the trt landscape for DLBCL in KOR"
Diego Santoro, Head of the International Region for Kite Pharma
Dong-A ST launches Sterlara biosimilar Imuldosa in the US
V-olet challenges to become a blockbuster fat-destroying inj
Kim Seul-ki, PM of Daewoong Pharmaceutical's Nabota Business Team
'Viatris will lead market with innovation and leadership'
Bill Schuster, Representative Director & Country Manager of Viatris Korea
"Livtencity offers new CMV trt for transplant patients"
Dr. Sang-Oh Lee, professor at Seoul Asan Medical Center's Department of Infectious Diseases
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Will the new GVHD drug Rezurock be reimbursed in 2H?
2
Sanofi-MTPK sign exclusive sales agreement for Aubagio
3
Spray formulation of 'nicotine' wins nod in KOR as OTC
4
"Gov't actively supports the development of new drugs"
5
Samjin Pharm and Sanofi collide in the influenza vaccine mkt
6
US pressures MFNs to cut drug prices
7
Did companies pre-stock inventories in the U.S.?
8
Bill bans remote narcotics and hair loss drug prescriptions
9
Vivozon "Joint sales of Unafra with Daiichi Sankyo"
10
"PSA test determines prostate cancer survival rate"